Wide Ranks

ENOV

Enovis Corporation

48.45

Top Statistics
Market Cap 2 B Forward PE 15.32 Revenue Growth 21.00 %
Current Ratio 2.27 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -5.96 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 13.79 Enterprise / Revenue 2.04 Price To Sales Trailing12 Months 1.35
Profitability
Profit Margins -5.96 % Operating Margins 1.15 %
Balance Sheet
Total Cash 35 M Total Cash Per Share 0.6340 Total Debt 1 B
Total Debt To Equity 42.43 Current Ratio 2.27 Book Value Per Share 59.61
All Measures
Short Ratio 599.00 % Message Board Id finmb_617309 Shares Short Prior Month 4 M
Return On Equity -0.0356 City Wilmington Uuid 1ea9bec5-9b1b-359b-b676-99c8688f4d1d
Previous Close 47.74 First Trade Date Epoch Utc 1 B Book Value 59.61
Beta 2.00 Total Debt 1 B Volume 475747
Price To Book 0.8127 Last Split Date 1 B Fifty Two Week Low 38.27
Total Cash Per Share 0.6340 Total Revenue 2 B Shares Short Previous Month Date 1 B
Target Median Price 64.50 Max Age 86400 Recommendation Mean 1.45
Sand P52 Week Change 0.3133 Operating Margins 1.15 % Target Mean Price 66.30
Net Income To Common -121380000 Ask 48.61 Short Percent Of Float 0.0905
Implied Shares Outstanding 55 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 567200 Average Volume10days 567200 Total Cash 35 M
Next Fiscal Year End 1 B Revenue Per Share 36.43 Held Percent Insiders 0.0095
Ebitda Margins 14.81 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 47.74 Target Low Price 50.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 43.01 Open 47.91
Free Cashflow -80950376 State DE Dividend Yield 0.00 %
Return On Assets 0.0037 Time Zone Short Name EST Trailing Eps -2.21
Day Low 47.75 Address1 2711 Centerville Road Shares Outstanding 55 M
Price Hint 2 Target High Price 75.00 Website https://www.enovis.com
52 Week Change -0.0204 Average Volume 663101 Forward Eps 3.16
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 82.20 %
Last Split Factor 581:1000 Regular Market Day High 48.90 Is_sp_500 False
Profit Margins -5.96 % Debt To Equity 42.43 Fifty Two Week High 65.03
Day High 48.90 Shares Short 4 M Regular Market Open 47.91
Industry Key specialty-industrial-machinery Bid 48.00 Earnings Growth 0.00 %
Enterprise To Revenue 2.04 Revenue Growth 21.00 % Shares Percent Shares Out 0.0791
Operating Cashflow 93 M Currency USD Time Zone Full Name America/New_York
Market Cap 2 B Is_nasdaq_100 False Zip 19808
Quote Type EQUITY Industry Specialty Industrial Machinery Long Name Enovis Corporation
Regular Market Day Low 47.75 Held Percent Institutions 1.11 Current Price 48.45
Address2 Suite 400 Enterprise To Ebitda 13.79 Financial Currency USD
Current Ratio 2.27 Gross Margins 58.95 % Industry Disp Specialty Industrial Machinery
Number Of Analyst Opinions 10 Country United States Float Shares 53 M
Two Hundred Day Average 49.06 Enterprise Value 4 B Price To Sales Trailing12 Months 1.35
Forward PE 15.32 Regular Market Volume 475747 Ebitda 296 M
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide.

It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy.

The company operates through Prevention and Recovery, and Reconstructive segments.

Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals.

The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools.

The company distributes its products through independent distributors and directly under the ESAB and DJO brands.

Enovis Corporation was formerly known as Colfax Corporation.

The company was founded in 1995 and is headquartered in Wilmington, Delaware.